[1]
“The role of GLP-1 receptor agonists in obese patients with Polycystic Ovary Syndrome: an integrative review of the literature”, RSD, vol. 12, no. 9, p. e9212943306, Sep. 2023, doi: 10.33448/rsd-v12i9.43306.